Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Br...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Mulualem Tesfaye Birhan, Teklie Mengie Ayele, Fikire Wondimu Abebe and Fiseha Nigussie Dgnew Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Men | Metabolic Syndrome